Sharma ND (2026). [PMID: 41129238](https://pubmed.ncbi.nlm.nih.gov/41129238/). *J Clin Invest*. [Basic Science / Preclinical]
Bychkov G (2026). [PMID: 41996759](https://pubmed.ncbi.nlm.nih.gov/41996759/). *Cancer Epidemiol*. [Epidemiology / Natural History]
Mohapatra D (2026). [PMID: 41843833](https://pubmed.ncbi.nlm.nih.gov/41843833/). *JCO Glob Oncol*. [Review / Meta-Analysis]
Sandmann S (2026). [PMID: 41927524](https://pubmed.ncbi.nlm.nih.gov/41927524/). *Blood Cancer J*. [Basic Science / Preclinical]
Xu J (2026). [PMID: 41436318](https://pubmed.ncbi.nlm.nih.gov/41436318/). *Trends Cancer*. [Review / Meta-Analysis]
Pegoraro F (2026). [PMID: 41881068](https://pubmed.ncbi.nlm.nih.gov/41881068/). *JCO Precis Oncol*. [Gene Therapy / Novel Therapeutics]
Zhizhuo H (2026). [PMID: 41496266](https://pubmed.ncbi.nlm.nih.gov/41496266/). *Cancer Treat Res Commun*. [Clinical Trial Publication]
Jaspersen SL (2026). [PMID: 41925077](https://pubmed.ncbi.nlm.nih.gov/41925077/). *Pediatr Blood Cancer*. [Case Report / Case Series]
McCall D (2026). [PMID: 40324358](https://pubmed.ncbi.nlm.nih.gov/40324358/). *Acta Haematol*. [Review / Meta-Analysis]
Hamidi R (2026). [PMID: 41747190](https://pubmed.ncbi.nlm.nih.gov/41747190/). *Blood Adv*. [Review / Meta-Analysis]
